LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 29, 2019-- LabCorp® (NYSE: LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference . LabCorp’s presentation is planned for Monday, Sept. 9, 2019 at 9:55 a.m. ET . A live audio webcast will be available via the Company

Covance Launches Laboratory Data Management Functional Service Provider for Pharmaceutical and Biotechnology Customers

Program Expands the Company’s Growing and Unique FSPx Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 29, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development business has launched a laboratory solution within its functional

LabCorp Announces 2019 Second Quarter Results and Updates 2019 Guidance

Q2 revenue of $2.88 billion , up 0.5% from $2.87 billion last year; excluding the disposition of businesses revenue grew 2.4% Q2 diluted EPS of $1.93 , down 15% from $2.27 last year; Q2 adjusted EPS of $2.93 , down 2% from $2.98 last year 2019 adjusted EPS guidance of $11.10 to $11.40 , up 1% to 3%

LabCorp Expands Consumer-Initiated Test Offering

Pixel by LabCorp Now Available with Phlebotomy Collection Through LabCorp’s Nationwide Patient Service Center Network BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 22, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced a significant expansion to its Pixel by LabCorp™

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2019-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

LabCorp to Announce Second Quarter Financial Results on July 25, 2019

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2019-- LabCorp® (NYSE: LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 25, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

Philips IntelliSite Pathology Solution will be deployed across the Mount Sinai Health System to support greater efficiency and help improve patient care BURLINGTON, N.C. & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Jun. 18, 2019-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced

LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

LabCorp Announces New Leadership Roles

David P. King , current chairman, president and CEO of LabCorp, to become executive chairman of the board of directors effective Nov. 1 , retiring Oct. 31 as president and CEO Adam H. Schechter , current lead independent director of LabCorp and longtime Merck executive, to become president and CEO

LabCorp Announces New Term Loan Facility

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 3, 2019-- On June 3, 2019 , LabCorp® (NYSE: LH) entered into a new Term Loan Credit Agreement, which provides for a two-year term loan credit facility in the principal amount of $850 million (the “New Term Loan Facility”). Bank of America, N.A.